Insmed (INSM) announced that the U.S. FDA has accepted the company’s New Drug Application for brensocatib for patients with non-cystic fibrosis bronchiectasis. In its Day 60 communication to ...

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, monobactam/beta-lactamase inhibitor combination antibiotic.

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema. Susvimo is the first and only ...

Derek Maltz formerly worked at PenLink, a Nebraska-based tech firm that has sold software that can track phone locations ...

THURSDAY, Feb. 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion ...

Music industry mourns the loss of Irv Gotti, the visionary behind Murder Inc. Records and architect of numerous hip-hop and R ...

The 34-year-old son of NBA great Michael Jordan was arrested early Tuesday in central Florida on a misdemeanor drug charge after police officers found his car stuck on railroad tracks minutes ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...

The U.S. Food and Drug Administration (FDA) has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease. “The approval of once every four-week ...

European stocks rise ahead of BOE rate decision; SocGen soars By Investing.com - 2 hours ago Investing.com - European stock markets rose Thursday, as investors awaited a rate decision by the Bank of ...